Pixium Vision Logo

Pixium Vision

ISIN: FR0011950641 | Ticker: ALPIX | LEI: 96950046OPLRLKKEOO08
Sector: Health CareSub-Industry: Health Care Equipment
Country: France

About Pixium Vision

Company Description

Pixium Vision, created in December 2011, is a bioelectronics and brain machine interface technology company specialized in neuromodulation application whose mission is to create a world of bionic vision for those who have lost their sight, enabling them to regain partial visual perception and greater autonomy.

Prima System features a miniaturized and totally wireless sub-retinal PRIMA implant, a pocket computer equipped with breakthrough algorithms, and a pair of glasses which captures the visual scene.

For the novel breakthrough Prima system, the exclusive transfer of the patented technology was granted by Stanford’s University to Pixium Vision to develop and industrialize the PRIMA bionic vision system.

Pixium Vision is currently conducting in France and in the United States, two feasibility clinical trials with PRIMA, for patients with severe vision loss due to retinal degeneration caused by the dry atrophic form of Age-related Macular Degeneration (AMD).

Year founded

2011

Served area

Worldwide

Headcount

51

Headquarters

74 Rue du Faubourg Saint Antoine, 75012 Paris – France

Insider Trades

Date Trading entity / Person Association Trade type Volume
10.01.24 None Other Sell EUR 16,517.55
09.01.24 None Other Sell EUR 45,608.54
08.01.24 None Other Sell EUR 69,732.98
04.12.23 None Other Sell EUR 60.98

Capital markets information

ISIN

FR0011950641

LEI

96950046OPLRLKKEOO08

Sector

Health Care

Industry Group

Health Care Equipment & Services

Industry

Health Care Equipment & Supplies

Sub-Industry

Health Care Equipment

Listed Stock Exchange

Euronext Paris

Main Stock Exchange

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.